Ocugen Quote - OCGN

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.72

Bid

0.72

Ask

0.735

Volume

2,407,168

0.7252 Day's Range 0.7704

0.495 52 Week Range 2.105

Market Cap

209.751M

Previous Close

0.7692

Open

0.7704

Last Trade

0.7349

Last Trade Time

Financial Volume

US$ 1,796,689

VWAP

0.746391

Average Volume (3m)

4,885,665

Shares Outstanding

291,320,280

Dividend Yield

PE Ratio

-3.37

Earnings Per Share (EPS)

-0.22

Revenue

6.04M

Net Profit

-63.08M

Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal... Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Ortho,prosth,surg Appl,suply

Website

ocugen.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Ocugen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker OCGN. The last closing price for Ocugen was US$0.77. Over the last year, Ocugen shares have traded in a share price range of US$ 0.495 to US$ 2.105.

Ocugen currently has 291,320,280 shares outstanding. The market capitalization of Ocugen is US$224.08 million. Ocugen has a price to earnings ratio (PE ratio) of -3.37.

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Ocugen, Inc. Announces Investigational New Drug Application in Effect After Review by FDA to Initiate Phase 1 Clinical Trial Evaluating First-in-Class OCU500 Inhaled Vaccine Candidate for COVID-19

OCU500 will be administered via inhalation and as a nasal sprayCOVID-19 remains a substantial public health threat in the U.S. and around the worldPhase 1 clinical trial is anticipated to start in...

Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200—a Novel Integrin-Targeting Biologic for Diabetic Macular Edema

MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel...

Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 —A Novel Modifier Gene Therapy for Retinitis Pigmentosa

100% (9/9) of treated evaluable subjects demonstrated improvement or preservation in visual function compared to untreated eyes at both one and two years100% (9/9) of treated evaluable subjects...

Form 4 - Statement of changes in beneficial ownership of securities

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

OCU410 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reported, such as exudation, infectious endophthalmitis, intraocular...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0659	-8.38529074946	0.7859	0.8199	0.705	3574256	0.745856	CS
4	-0.26	-26.5306122449	0.98	1	0.695	4499000	0.77881322	CS
12	-0.37	-33.9449541284	1.09	1.13	0.69	4885665	0.84263373	CS
26	-0.77	-51.677852349	1.49	1.5	0.69	4343795	0.99094116	CS
52	0.1656	29.8701298701	0.5544	2.105	0.495	5933574	1.27051851	CS
156	-2.5	-77.6397515528	3.22	4.53	0.345	5875529	1.60002673	CS
260	0.2046	39.697322468	0.5154	18.77	0.17	16595703	5.38658165	CS

OCGN - Frequently Asked Questions (FAQ)

What is the current Ocugen share price?

The current share price of Ocugen is US$ 0.72

How many Ocugen shares are in issue?

Ocugen has 291,320,280 shares in issue

What is the market cap of Ocugen?

The market capitalisation of Ocugen is USD 224.08M

What is the 1 year trading range for Ocugen share price?

Ocugen has traded in the range of US$ 0.495 to US$ 2.105 during the past year

What is the PE ratio of Ocugen?

The price to earnings ratio of Ocugen is -3.37

What is the cash to sales ratio of Ocugen?

The cash to sales ratio of Ocugen is 35.27

What is the reporting currency for Ocugen?

Ocugen reports financial results in USD

What is the latest annual turnover for Ocugen?

The latest annual turnover of Ocugen is USD 6.04M

What is the latest annual profit for Ocugen?

The latest annual profit of Ocugen is USD -63.08M

What is the registered address of Ocugen?

The registered address for Ocugen is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Ocugen website address?

The website address for Ocugen is ocugen.com

Which industry sector does Ocugen operate in?

Ocugen operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	731.1M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.5M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	341.8M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	237.15M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.44M

Symbol

Price

Vol.

TCTMTCTM Kids IT Education Inc

US$ 0.764

(321.87%)

731.1M

NVDANVIDIA Corporation

US$ 120.07

(-3.67%)

388.5M

RIMEAlgorhythm Holdings Inc

US$ 0.02565

(5.12%)

341.8M

CLEUChina Liberal Education Holdings Ltd

US$ 0.1938

(30.77%)

237.15M

BHATBlue Hat Interactive Entertainment Technology

US$ 0.0355

(-11.25%)

236.44M

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Ocugen Inc (OCGN) Share Price

Ocugen Inc (OCGN)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

About Ocugen Inc

Ask ADVFN Intelligence (AI)

OCGN Latest News

OCGN - Frequently Asked Questions (FAQ)

Movers

OCGN Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free